BR9608132A - Processos para manter tecido viável separado em relacionamento proximal e selar um defeito em tecido viável, kit, e, composição de proteìna reticulada. - Google Patents

Processos para manter tecido viável separado em relacionamento proximal e selar um defeito em tecido viável, kit, e, composição de proteìna reticulada.

Info

Publication number
BR9608132A
BR9608132A BR9608132-5A BR9608132A BR9608132A BR 9608132 A BR9608132 A BR 9608132A BR 9608132 A BR9608132 A BR 9608132A BR 9608132 A BR9608132 A BR 9608132A
Authority
BR
Brazil
Prior art keywords
viable tissue
kit
defect
processes
separated
Prior art date
Application number
BR9608132-5A
Other languages
English (en)
Inventor
Erwin R Stedronsky
Joseph Cappello
Original Assignee
Protein Polymer Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Polymer Tech Inc filed Critical Protein Polymer Tech Inc
Publication of BR9608132A publication Critical patent/BR9608132A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier

Abstract

"PROCESSOS PARA MANTER TECIDO VIáVEL SEPARADO EM RELACIONAMENTO PROXIMAL E SELAR UM DEFEITO EM TECIDO VIáVEL, KIT, E, COMPOSIçãO DE PROTEìNA RETICULADA". Os polímeros proteináceos, tendo unidades repetitivas de proteínas estruturais de ocorrência natural, são empregados como espinhas dorsais para as funcionalidades de reticulação, para prover adesivos e selantes de tecidos fortemente aderentes. Particularmente, os copolímeros em bloco de elastina e fibroína são empregados tendo as substituições de lisina em unidades separadas por espaços, onde o grupo amino pode ser reticulado usando-se agentes de reticulação difuncional.
BR9608132-5A 1995-05-05 1996-05-02 Processos para manter tecido viável separado em relacionamento proximal e selar um defeito em tecido viável, kit, e, composição de proteìna reticulada. BR9608132A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/435,641 US5817303A (en) 1995-05-05 1995-05-05 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
PCT/US1996/006229 WO1996034618A1 (en) 1995-05-05 1996-05-02 Tissue adhesive using synthetic cross-linking

Publications (1)

Publication Number Publication Date
BR9608132A true BR9608132A (pt) 1999-12-07

Family

ID=23729204

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608132-5A BR9608132A (pt) 1995-05-05 1996-05-02 Processos para manter tecido viável separado em relacionamento proximal e selar um defeito em tecido viável, kit, e, composição de proteìna reticulada.

Country Status (10)

Country Link
US (7) US5817303A (pt)
EP (2) EP0823848A4 (pt)
JP (1) JP4088341B2 (pt)
KR (1) KR19990008330A (pt)
AU (1) AU692391B2 (pt)
BR (1) BR9608132A (pt)
CA (1) CA2219020A1 (pt)
MX (1) MX9708476A (pt)
NZ (1) NZ307794A (pt)
WO (1) WO1996034618A1 (pt)

Families Citing this family (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817303A (en) * 1995-05-05 1998-10-06 Protein Polymer Technologies, Inc. Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
US5874500A (en) 1995-12-18 1999-02-23 Cohesion Technologies, Inc. Crosslinked polymer compositions and methods for their use
US7883693B2 (en) 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
AU4648697A (en) * 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US8003705B2 (en) * 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US6015474A (en) * 1997-06-20 2000-01-18 Protein Polymer Technologies Methods of using primer molecules for enhancing the mechanical performance of tissue adhesives and sealants
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
JP2002531217A (ja) * 1998-12-04 2002-09-24 チャンドラシェカー ピー． パサック， 生体適合性架橋ポリマー
DE19858463A1 (de) * 1998-12-18 2000-06-21 Centeon Pharma Gmbh Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes
US20040110722A1 (en) * 1999-05-27 2004-06-10 Ornberg Richard L. Modified hyaluronic acid polymers
JP2003500174A (ja) 1999-05-27 2003-01-07 フアルマシア・コーポレーシヨン スーパーオキシド・ジスムターゼ模倣体で修飾された生体材料
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
US6902564B2 (en) * 2001-08-15 2005-06-07 Roy E. Morgan Methods and devices for electrosurgery
US7445619B2 (en) * 2000-08-18 2008-11-04 Map Technologies Llc Devices for electrosurgery
US20040167244A1 (en) * 2000-08-18 2004-08-26 Auge Wayne K. Methods and compositions for fusing bone during endoscopy procedures
US7771422B2 (en) 2002-06-06 2010-08-10 Nuortho Surgical, Inc. Methods and devices for electrosurgery
US7819861B2 (en) * 2001-05-26 2010-10-26 Nuortho Surgical, Inc. Methods for electrosurgical electrolysis
US6547794B2 (en) 2000-08-18 2003-04-15 Auge', Ii Wayne K. Method for fusing bone during endoscopy procedures
AU1538702A (en) * 2000-10-24 2002-05-06 Cryolife Inc In situ bioprosthetic filler and methods, particularly for the in situ formationof vertebral disc bioprosthetics
CA2425935C (en) * 2000-11-07 2011-03-29 Cryolife, Inc. Expandable foam-like biomaterials and methods
DE60207902T2 (de) * 2001-01-30 2006-06-14 Nissan Chemical Ind Ltd Isocyanuratverbindung und Verfahren zu ihrer Herstellung
US7066932B1 (en) 2001-05-26 2006-06-27 Map Technologies Llc Biologically enhanced irrigants
WO2002096978A1 (fr) * 2001-05-30 2002-12-05 Keiichi Miyamoto Elastine reticulee et son procede de production
US8591508B2 (en) * 2001-08-15 2013-11-26 Nuortho Surgical, Inc. Electrosurgical plenum
US8235979B2 (en) 2001-08-15 2012-08-07 Nuortho Surgical, Inc. Interfacing media manipulation with non-ablation radiofrequency energy system and method
US8734441B2 (en) * 2001-08-15 2014-05-27 Nuortho Surgical, Inc. Interfacing media manipulation with non-ablation radiofrequency energy system and method
US20050090641A1 (en) * 2001-10-02 2005-04-28 Regina Valluzzi Self-assembling polymers, and materials fabricated therefrom
US7799833B2 (en) 2001-11-01 2010-09-21 Spine Wave, Inc. System and method for the pretreatment of the endplates of an intervertebral disc
AU2002336694A1 (en) 2001-11-01 2003-05-12 Lawrence M. Boyd Devices and methods for the restoration of a spinal disc
US8501165B2 (en) 2001-12-12 2013-08-06 Promethean Surgical Devices Llc In situ bonds
CA2473772A1 (en) * 2002-02-14 2003-08-21 The University Of British Columbia .alpha.-helical protein based materials and methods for making same
BRPI0312331A2 (pt) * 2002-07-03 2016-06-28 Pericor Science Inc composições de ácido hialurônico e métodos de emprego.
US7745532B2 (en) * 2002-08-02 2010-06-29 Cambridge Polymer Group, Inc. Systems and methods for controlling and forming polymer gels
US7485670B2 (en) * 2002-08-02 2009-02-03 Cambridge Polymer Group, Inc. Systems and methods for controlling and forming polymer gels
US10098981B2 (en) 2002-08-06 2018-10-16 Baxter International Inc. Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
US9101536B2 (en) * 2002-08-06 2015-08-11 Matrix Medical Llc Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
US8349348B2 (en) * 2002-08-06 2013-01-08 Matrix Medical, Llc Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
ES2703438T3 (es) 2002-08-06 2019-03-08 Baxter Int Composiciones proteicas de fase reversible biocompatible y métodos para prepararlas y usarlas
DE10236152A1 (de) * 2002-08-07 2004-02-19 Marker Deutschland Gmbh Ski- und Skibindungs-Kombination
US20050142094A1 (en) * 2003-03-12 2005-06-30 Manoj Kumar Use of repeat sequence protein polymers in personal care compositions
US7297678B2 (en) * 2003-03-12 2007-11-20 Genencor International, Inc. Use of repeat sequence protein polymers in personal care compositions
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7632294B2 (en) 2003-09-29 2009-12-15 Promethean Surgical Devices, Llc Devices and methods for spine repair
WO2005041987A1 (en) * 2003-10-29 2005-05-12 Gentis, Inc. Polymerizable emulsions for tissue engineering
JP4440939B2 (ja) * 2004-01-08 2010-03-24 スパイン・ウェイブ・インコーポレーテッド 伸延した組織部位に流動性材料を注入する装置及び方法
US8067031B2 (en) * 2004-04-28 2011-11-29 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
WO2006009688A2 (en) * 2004-06-16 2006-01-26 Pneumrx, Inc. Intra-bronchial lung volume reduction system
US7837733B2 (en) * 2004-06-29 2010-11-23 Spine Wave, Inc. Percutaneous methods for injecting a curable biomaterial into an intervertebral space
US8303973B2 (en) 2004-09-17 2012-11-06 Angiotech Pharmaceuticals (Us), Inc. Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
US9707252B2 (en) * 2005-02-09 2017-07-18 Covidien Lp Synthetic sealants
US7825083B2 (en) * 2005-02-10 2010-11-02 Spine Wave, Inc. Synovial fluid barrier
US20080287635A1 (en) * 2005-04-22 2008-11-20 Xiuzhui Sun Latex Adhesives Derived From Ionic Strength Induced Soy Protein Complexes
EP1888136A2 (en) * 2005-05-18 2008-02-20 The General Hospital Corporation doing business as Massachusetts General Hospital Hydrogels and hydrogel particles
ES2330904B1 (es) * 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
WO2007093042A1 (en) * 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
WO2007140312A2 (en) * 2006-05-25 2007-12-06 The General Hospital Corporation Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
WO2008036763A2 (en) * 2006-09-20 2008-03-27 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20090227981A1 (en) * 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
US20090227689A1 (en) * 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
US8911750B2 (en) * 2007-04-03 2014-12-16 Larry W. Tsai Lung volume reduction therapy using crosslinked biopolymers
EP2014280B1 (en) * 2007-07-13 2014-10-08 CC-Ery GmbH Micro-particles, blood-substitute and method for forming same
US8182647B2 (en) 2007-07-23 2012-05-22 Cohera Medical, Inc. Hydrophilic biodegradable adhesives
US8067028B2 (en) * 2007-08-13 2011-11-29 Confluent Surgical Inc. Drug delivery device
HUE025522T2 (en) 2007-12-03 2016-02-29 Tenaxis Medical Inc Biocompatible, convertible phase protein-like composition
CA2723824C (en) 2008-05-09 2022-12-06 Surmodics Pharmaceuticals, Inc. Biocompatible and biodegradable elastomeric polymers
JP2011524367A (ja) 2008-06-12 2011-09-01 メドトロニック・ゾーメド・インコーポレーテッド 慢性の創傷を治療するための方法
RU2523314C2 (ru) * 2008-09-08 2014-07-20 Геркулес Инкорпорейтед Композиции, включающие белок и катионный полимер, и обладающие пониженной вязкостью
US20100086576A1 (en) 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
MX2011009084A (es) 2009-03-06 2012-01-25 Biopolymer Technologies Ltd Espumas que contienen proteinas, su produccion y sus usos.
WO2010102284A2 (en) 2009-03-06 2010-09-10 Parker Anthony A Protein-containing emulsions and adhesives, and manufacture and use thereof
US20100261652A1 (en) * 2009-04-08 2010-10-14 California Institute Of Technology Tissue Adhesive Using Engineered Proteins
US9155815B2 (en) 2009-04-17 2015-10-13 Tenaxis Medical, Inc. Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
US20110106354A1 (en) * 2009-04-30 2011-05-05 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280707A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280690A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280693A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280709A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280705A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20110106591A1 (en) * 2009-04-30 2011-05-05 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280887A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding privileges to a vehicle based upon one or more fuel utilization characteristics
US20100280885A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding privileges to a vehicle based upon one or more fuel utilization characteristics
US20100280708A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280706A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280692A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280689A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280886A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delware Awarding privileges to a vehicle based upon one or more fuel utilization characteristics
US20100280704A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US20100280686A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding privileges to a vehicle based upon one or more fuel utilization characteristics
US8855907B2 (en) * 2009-04-30 2014-10-07 Searete Llc Awarding privileges to a vehicle based upon one or more fuel utilization characteristics
US20100280691A1 (en) * 2009-04-30 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Awarding standings to a vehicle based upon one or more fuel utilization characteristics
US9532827B2 (en) 2009-06-17 2017-01-03 Nuortho Surgical Inc. Connection of a bipolar electrosurgical hand piece to a monopolar output of an electrosurgical generator
US10159825B2 (en) 2009-09-17 2018-12-25 Zipline Medical, Inc. Rapid closing surgical closure device
US9132207B2 (en) * 2009-10-27 2015-09-15 Spine Wave, Inc. Radiopaque injectable nucleus hydrogel compositions
US20130190788A1 (en) * 2010-04-27 2013-07-25 Covalent Medicals Inc Methods and compositions for repair of vascular tissue
DK2576661T3 (en) 2010-06-07 2017-03-20 Evertree PROTEIN-CONTAINING ADHESIVES, THEIR PREPARATION AND APPLICATION THEREOF
WO2011159623A1 (en) 2010-06-14 2011-12-22 Zipline Medical, Inc. Methods and apparatus for inhibiting scar formation
EP2676683B1 (en) * 2011-02-18 2016-09-21 Kyoto University Aqueous protein solution containing a material for tissue regeneration
US9408658B2 (en) 2011-02-24 2016-08-09 Nuortho Surgical, Inc. System and method for a physiochemical scalpel to eliminate biologic tissue over-resection and induce tissue healing
US9700425B1 (en) 2011-03-20 2017-07-11 Nuvasive, Inc. Vertebral body replacement and insertion methods
US20120276008A1 (en) * 2011-04-26 2012-11-01 Spine Wave, Inc. Radiopaque injectable nucleus hydrogel compositions
JP5955674B2 (ja) * 2011-07-19 2016-07-20 三洋化成工業株式会社 褥瘡予防材及びこれを含む褥瘡予防用タンパク質水溶液
LT2753633T (lt) 2011-09-09 2017-04-10 Evertree Baltymo turintys klijai, jų gamyba ir panaudojimas
WO2013036739A1 (en) 2011-09-09 2013-03-14 Biopolymer Technologies, Ltd. Protein-containing adhesives, and manufacture and use thereof
US9561034B2 (en) * 2011-11-01 2017-02-07 Zipline Medical, Inc. Surgical incision and closure apparatus
US10123800B2 (en) 2011-11-01 2018-11-13 Zipline Medical, Inc. Surgical incision and closure apparatus with integrated force distribution
US10123801B2 (en) 2011-11-01 2018-11-13 Zipline Medical, Inc. Means to prevent wound dressings from adhering to closure device
JP6017776B2 (ja) * 2011-11-24 2016-11-02 三洋化成工業株式会社 細胞集合体培養用基材及び細胞集合体の生産方法
JP6050609B2 (ja) * 2012-05-31 2016-12-21 三洋化成工業株式会社 皮膚弾性向上材及び皮膚弾性向上用タンパク質溶液
MX2015000863A (es) 2012-07-19 2016-05-05 Alethia Biotherapeutics Inc Anticuerpos anti-siglec-15.
EP3666845A1 (en) 2012-07-30 2020-06-17 Evertree Protein adhesives containing an anhydride, carboxylic acid, and/or carboxylate salt compound and their use
JP6253875B2 (ja) * 2012-09-19 2017-12-27 三洋化成工業株式会社 コラーゲン産生促進剤、コラーゲン産生促進用培養液、抗老化剤、コラーゲン産生促進用ゲル、及び、コラーゲン産生用ゲルの製造方法
US9579142B1 (en) 2012-12-13 2017-02-28 Nuortho Surgical Inc. Multi-function RF-probe with dual electrode positioning
JP6496484B2 (ja) * 2013-02-12 2019-04-03 三洋化成工業株式会社 創傷治癒剤
CN114306571A (zh) * 2013-02-22 2022-04-12 三洋化成工业株式会社 创伤治愈剂
US9040093B2 (en) 2013-03-13 2015-05-26 Orthovita, Inc. Bone graft materials containing calcium phosphate and chitosan
JP6326326B2 (ja) * 2013-08-30 2018-05-16 三洋化成工業株式会社 創傷治癒剤
EP3089677B1 (en) 2014-01-05 2020-04-01 Zipline Medical, Inc. Instrumented wound closure device
US10294195B2 (en) 2014-01-31 2019-05-21 Seikagaku Corporation Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials
JP6498961B2 (ja) * 2014-02-27 2019-04-10 三洋化成工業株式会社 癒着防止剤及び癒着防止剤組成物
JP6754982B2 (ja) * 2015-05-20 2020-09-16 国立大学法人京都大学 発育障害抑制材
US10931682B2 (en) * 2015-06-30 2021-02-23 Microsoft Technology Licensing, Llc Privileged identity management
US20170087272A1 (en) * 2015-07-22 2017-03-30 Hans P.I. Claesson Collagen based materials and methods of using them
WO2018081795A1 (en) 2016-10-31 2018-05-03 Zipline Medical, Inc. Systems and methods for monitoring physical therapy of the knee and other joints
WO2019231763A1 (en) 2018-05-27 2019-12-05 Christos Angeletakis Tissue adhesives and sealants using naturally derived aldehydes
CN112292157A (zh) 2018-06-12 2021-01-29 国立大学法人京都大学 细胞移植用组合物和细胞移植方法
GB2574074B (en) 2018-07-27 2020-05-20 Mclaren Applied Tech Ltd Time synchronisation
CN112789063B (zh) 2018-10-05 2022-10-25 国立大学法人广岛大学 半月板再生用材料
CN110639062A (zh) * 2018-12-17 2020-01-03 中鼎凯瑞科技成都有限公司 一种温度与模量双控型纳米羟基磷灰石聚氨基酸复合骨移植材料及其制备方法
GB2588236B (en) 2019-10-18 2024-03-20 Mclaren Applied Ltd Gyroscope bias estimation
CN114746128B (zh) * 2019-12-02 2023-04-28 国立大学法人京都大学 支气管栓塞材料
CN111802385B (zh) * 2020-02-29 2021-08-31 西安曼特思生物科技有限公司 一种可固定目标物并可按需清除的蛋白质产品
US11413795B1 (en) * 2021-08-12 2022-08-16 King Abdulaziz University Method of making composite from green material

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187852A (en) * 1976-07-09 1980-02-12 The University Of Alabama Synthetic elastomeric insoluble cross-linked polypentapeptide
US4589882A (en) * 1983-09-19 1986-05-20 Urry Dan W Enzymatically crosslinked bioelastomers
US5064430A (en) * 1985-10-31 1991-11-12 Uab Research Foundation Polynonapeptide bioelastomers having an increased elastic modulus
US5336256A (en) * 1986-04-17 1994-08-09 Uab Research Foundation Elastomeric polypeptides as vascular prosthetic materials
US4898926A (en) * 1987-06-15 1990-02-06 The University Of Alabama At Birmingham/Research Foundation Bioelastomer containing tetra/penta-peptide units
US5514581A (en) * 1986-11-04 1996-05-07 Protein Polymer Technologies, Inc. Functional recombinantly prepared synthetic protein polymer
US5496712A (en) * 1990-11-06 1996-03-05 Protein Polymer High molecular weight collagen-like protein polymers
US5243038A (en) * 1986-11-04 1993-09-07 Protein Polymer Technologies, Inc. Construction of synthetic DNA and its use in large polypeptide synthesis
US6184348B1 (en) * 1986-11-04 2001-02-06 Protein Polymer Technologies Functional recombinantly prepared synthetic protein polymer
US4743632A (en) * 1987-02-25 1988-05-10 Pfizer Hospital Products Group, Inc. Polyetherurethane urea polymers as space filling tissue adhesives
US5024742A (en) 1988-02-24 1991-06-18 Cedars-Sinai Medical Center Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers
US5350583A (en) * 1988-03-09 1994-09-27 Terumo Kabushiki Kaisha Cell-penetrable medical material and artificial skin
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5197973A (en) * 1990-12-14 1993-03-30 Creative Biomolecules, Inc. Synthetic bioadhesive
JPH04334396A (ja) * 1991-05-09 1992-11-20 Hitachi Chem Co Ltd リジン、チロシンを含むタンパク質の不溶化方法及び不溶化タンパク質
US5292333A (en) * 1991-09-05 1994-03-08 Beth Israel Hospital Biological tissue adhesion
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
US5428014A (en) * 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
KR950005997A (ko) * 1993-08-25 1995-03-20 노보루 시마자끼 인디고의 제조방법
AU2621295A (en) * 1994-05-24 1995-12-18 Smith & Nephew Plc Intervertebral disc implant
USRE38827E1 (en) * 1994-07-27 2005-10-11 3M Innovative Properties Company Adhesive sealant composition
US5583114A (en) * 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
US5817303A (en) * 1995-05-05 1998-10-06 Protein Polymer Technologies, Inc. Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer

Also Published As

Publication number Publication date
WO1996034618A1 (en) 1996-11-07
AU692391B2 (en) 1998-06-04
US7300663B2 (en) 2007-11-27
US20090023648A1 (en) 2009-01-22
EP1656946A1 (en) 2006-05-17
US6423333B1 (en) 2002-07-23
JPH11502537A (ja) 1999-03-02
EP0823848A4 (en) 2000-12-20
US5817303A (en) 1998-10-06
JP4088341B2 (ja) 2008-05-21
NZ307794A (en) 1999-07-29
US20090028813A1 (en) 2009-01-29
CA2219020A1 (en) 1996-11-07
KR19990008330A (ko) 1999-01-25
US20060029638A1 (en) 2006-02-09
US6033654A (en) 2000-03-07
AU5724096A (en) 1996-11-21
MX9708476A (es) 1998-06-28
US20030104589A1 (en) 2003-06-05
EP0823848A1 (en) 1998-02-18

Similar Documents

Publication Publication Date Title
BR9608132A (pt) Processos para manter tecido viável separado em relacionamento proximal e selar um defeito em tecido viável, kit, e, composição de proteìna reticulada.
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
Gibson et al. A collagen-like glycoprotein from elastin-rich tissues
Takeya et al. Primary structure of a hemorrhagic metalloproteinase, HT-2, isolated from the venom of Crotalus ruber ruber
EP0377836A3 (en) Method and composition to condition hair
PE20110236A1 (es) Proteccion y mejoramiento de celulas, tejidos y organos que responden a la eritropoyetina
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DE59910083D1 (de) Verwendung von Thiazolidin- oder Pyrrolidinderivaten von Aminosäuren als antihyperglykämische Mittel
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69906128D1 (de) Reaktionsprodukte von hyaluronsäure und natürlichen aminosäuren sowie deren verwendung in kosmetischen und pharmazeutischen zusammensetzungen
Tang et al. A diagonal electrophoretic method for selective purification of methionine peptides
Gross α, β-Unsaturated and related amino acids in peptides and proteins
Hirschmann et al. The collagen composition of the mandibular joint of the foetal calf
ATE168719T1 (de) Osteogene peptide
BR9814760A (pt) Proteìna anticongelamento, sequência de ácido nucléico, e, produto alimentìcio.
ES487926A0 (es) Procedimiento de fabricacion de compuestos que resultan de la fijacion de muramilpeptidos, sus homologos y derivados
ATE527364T1 (de) Polypeptide erhaltend eine modifizierte menschliche serum-albumin sekretions-pre-sequenz mit erhöhtem ausscheidungsertrag
Chung et al. Structural and functional studies on C4b-binding protein, a regulatory component of the human complement system
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
TR200201119T2 (tr) İnsan alfa1G-C-türü kalsiyum kanalı kodlayan DNA.
ATE42308T1 (de) Pharmakologisch aktive peptide.
NZ331771A (en) Lytic peptides with amphipathic alpha helices and positively charged N- or C-terminal, methods of activation/inactivation, compositions and methods of treatment are also included
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
Gaffney Fibrin (-ogen) interactions with plasmin
AU2676399A (en) Novel cystine knot protein and materials and methods for making it

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]